Co-authored by Sheena Wang and Ellie Purnell of HGF limited, “CRISPR and Agriculture” was originally published by Food and Drink
Continue Reading CRISPR and Agriculture
Co-authored by Sheena Wang and Ellie Purnell of HGF limited, “CRISPR and Agriculture” was originally published by Food and Drink …
Continue Reading CRISPR and AgricultureOnly days after lifting the nationwide preliminary injunction, the Fifth Circuit Court of Appeals vacated their decision to stay the…
Continue Reading Latest Update: Corporate Transparency Act Halted AgainAs an update to our posts on the ongoing attempts to block the Corporate Transparency Act, on December 23, 2024…
Continue Reading Update: Corporate Transparency Act Reinstated by Appeals Court: January 1 Deadline LoomsAs an update to our post on the Corporate Transparency Act, on December 3, 2024, a federal district court issued…
Continue Reading Update: The Corporate Transparency Act Put On HoldThe United States Patent and Trademark Office (USPTO) announced today the finalized fee increases taking effect on January 19, 2025.
Continue Reading USPTO Finalizes Fee Increases for 2025: What to Expect in the New Year and What to do NowThe utilization of artificial intelligence (“AI”) is becoming ubiquitous across a wide range of industry sectors. The biotech industry is…
Continue Reading Key Inventorship Considerations in AI-assisted Drug DevelopmentOur current food system is facing a myriad of critical challenges. The United Nations predicts that the world population will…
Continue Reading The Future of Food: Regulatory and Patent Landscape of Genome Editing in Food TechnologyThe Corporate Transparency Act (CTA) went into effect on January 1, 2024, and will impact millions of U.S. businesses by…
Continue Reading The Corporate Transparency Act: What you Need to Know to Comply with the New RequirementsThe food tech industry has been growing and evolving rapidly in the last ten years due to technological innovations in…
Continue Reading Meating of the Minds: Impossible Foods and Motif Foodworks Settle High Profile Patent Dispute in District CourtAs I have written about previously, the IP and competitive landscape for mRNA and lipid nanoparticles is complex. Pioneers, mid-stage…
Continue Reading Advanced IP Considerations for Cell-and-Gene Therapeutic Companies Utilizing Lipid Nanoparticle Delivery SystemsWe use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.